dopamine D2/D3 receptor modulators (Pfizer)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedopamine D2/D3 receptor modulators (Pfizer)
Drug Alias NamePD-158771 analogsdopamine D2/D3 agonists (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D2 receptor antagonistsDopamine D3 receptor agonists +[5] 
TargetsDopamine D2 receptorDopamine D3 receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis CorpPfizer Inc
Active IndicationsN/A
Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A